MediPharm Labs secures Costa Rican market entry through supply agreement

financialpost.com

MediPharm Labs will supply GMP-certified medicinal cannabis products to Costa Rica through a new supply agreement with Remidose Aerosols Inc. The agreement allows MediPharm Labs to enter the Costa Rican market, which officially opened for regulated sales in June 2025 and is projected to exceed $35 million annually. MediPharm Labs will provide oils, tinctures, inhalers, and dried flower to Remidose LATAM, which is licensed to import medicinal cannabis products into Costa Rica.


With a significance score of 1.3, this news ranks in the top ?% of today's 29712 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


MediPharm Labs secures Costa Rican market entry through supply agreement | News Minimalist